• 5. November 2024

Curetis and Acumen to Collaborate on Unyvero Sepsis Test and ASEAN Distribution

ByCuretis AG

Okt 5, 2015
#8722 Curetis licenses Acumen’s proprietary sepsis biomarker panel for use with Unyvero Platform
#8722 Diagnostics Development (DxD) Hub in Singapore to support Acumen in development and clinical validation of the panel
#8722 Acumen to distribute Unyvero product line in ASEAN countries

Teile den Beitrag mit Freunden